Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
暂无分享,去创建一个
[1] T. Arendt,et al. Pattern of tau isoforms expression during development in vivo , 2009, International Journal of Developmental Neuroscience.
[2] R. Crowther,et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.
[3] D. Holtzman,et al. Controlled Cortical Impact Traumatic Brain Injury in 3xTg-AD Mice Causes Acute Intra-Axonal Amyloid-β Accumulation and Independently Accelerates the Development of Tau Abnormalities , 2011, The Journal of Neuroscience.
[4] J. Trojanowski,et al. Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration , 2005, The Journal of Neuroscience.
[5] E. Mandelkow,et al. Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.
[6] Pedro Pesini,et al. Natural Non-Trasgenic Animal Models for Research in Alzheimer’s Disease , 2009, Current Alzheimer research.
[7] B. Yankner,et al. β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.
[8] Wolfgang Härtig,et al. Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals , 2003, The Journal of Neuroscience.
[9] J. Bamburg,et al. Rapid Changes in Phospho-MAP/Tau Epitopes during Neuronal Stress: Cofilin-Actin Rods Primarily Recruit Microtubule Binding Domain Epitopes , 2011, PloS one.
[10] M. Mattson. Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD , 1995, Neurobiology of Aging.
[11] A. Delacourte,et al. Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease , 1999, Brain pathology.
[12] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[13] F. LaFerla,et al. p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice , 2014, Neuroscience Letters.
[14] Meaghan Morris,et al. The Many Faces of Tau , 2011, Neuron.
[15] N. Hirokawa,et al. Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.
[16] H. Braak,et al. Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation , 2004, Neurobiology of Aging.
[17] B. Lu,et al. PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila , 2004, Cell.
[18] Jian-Zhi Wang,et al. Protein Phosphatase 2A Facilitates Axonogenesis by Dephosphorylating CRMP2 , 2010, The Journal of Neuroscience.
[19] Adriana B Ferreira,et al. The Generation of a 17 kDa Neurotoxic Fragment: An Alternative Mechanism by which Tau Mediates β-Amyloid-Induced Neurodegeneration , 2005, The Journal of Neuroscience.
[20] K. Kosik,et al. Phosphorylated tau and the neurodegenerative foldopathies. , 2005, Biochimica et biophysica acta.
[21] M. Kirschner,et al. Tau protein function in living cells , 1986, The Journal of cell biology.
[22] M. Goedert,et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.
[23] B. Ghetti,et al. Frontotemporal dementia: implications for understanding Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[24] A. Frankfurter,et al. Differential Localization of MAP‐2 and Tau in Mammalian Neurons in Situ a , 1986, Annals of the New York Academy of Sciences.
[25] N. Hirokawa,et al. Sorting mechanisms of Tau and MAP2 in neurons: Suppressed axonal transit of MAP2 and locally regulated microtubule binding , 1995, Neuron.
[26] Patrizia LoPresti,et al. Truncated Tau with the Fyn‐binding domain and without the microtubule‐binding domain hinders the myelinating capacity of an oligodendrocyte cell line , 2008, Journal of neurochemistry.
[27] P. Lantos,et al. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration , 2002, Journal of neuropathology and experimental neurology.
[28] Min Jae Lee,et al. Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system , 2013, Progress in Neurobiology.
[29] L. Behar,et al. Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal , 2001, The Journal of Neuroscience.
[30] M. Spillantini,et al. Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations , 2007, Brain pathology.
[31] Wendy Noble,et al. Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.
[32] M. Kirschner,et al. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.
[33] J. Sanes,et al. Mammalian SAD Kinases Are Required for Neuronal Polarization , 2005, Science.
[34] R. D'Hooge,et al. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau , 2012, Acta Neuropathologica.
[35] S. Halpain,et al. The MAP2/Tau family of microtubule-associated proteins , 2004, Genome Biology.
[36] J. Trojanowski,et al. The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice , 2012, The Journal of Neuroscience.
[37] Linda Partridge,et al. Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease , 2010, PLoS genetics.
[38] D. Gerlich,et al. Tubulin polyglutamylation stimulates spastin-mediated microtubule severing , 2010, The Journal of cell biology.
[39] Wen-Lang Lin,et al. Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species , 2006, The Journal of Neuroscience.
[40] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[41] Bruce S. McEwen,et al. Rapid and reversible changes in intrahippocampal connectivity during the course of hibernation in European hamsters , 2006, Proceedings of the National Academy of Sciences.
[42] D. Holtzman,et al. Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. , 2012, Brain : a journal of neurology.
[43] R. Nelson,et al. Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia , 2007, The Journal of Neuroscience.
[44] S. Andrews,et al. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse , 2012, Neurobiology of Aging.
[45] K. Kosik,et al. Selective Phosphorylation of Adult Tau Isoforms in Mature Hippocampal Neurons Exposed to Fibrillar Aβ , 1997, Molecular and Cellular Neuroscience.
[46] George Perry,et al. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. , 2003, The American journal of pathology.
[47] E. Mandelkow,et al. Amyloid‐β oligomers induce synaptic damage via Tau‐dependent microtubule severing by TTLL6 and spastin , 2013, The EMBO journal.
[48] H. Neumann,et al. Accumulation of tau induced in neurites by microglial proinflammatory mediators , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] N. Hirokawa,et al. Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons , 1996, The Journal of cell biology.
[50] T. Ben-Hur,et al. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics , 2008, Experimental Neurology.
[51] E. Mandelkow,et al. Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1 , 2007, The Journal of Neuroscience.
[52] J. Götz,et al. Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus , 2013, PloS one.
[53] L. Buée,et al. Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.
[54] M. Mesulam,et al. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy , 2003, Acta Neuropathologica.
[55] A. Ittner,et al. Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice , 2011, PloS one.
[56] Blaine R. Roberts,et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.
[57] B. Hyman,et al. Mechanisms of protein seeding in neurodegenerative diseases. , 2013, JAMA neurology.
[58] Rudi D'Hooge,et al. Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant , 2011, The Journal of Neuroscience.
[59] D. Holtzman,et al. Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo , 2013, Neuron.
[60] Cornelia M. Wilson,et al. Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A , 2013, Ageing Research Reviews.
[61] A. Erisir,et al. Tau-dependent microtubule disassembly initiated by prefibrillar β-amyloid , 2006, The Journal of cell biology.
[62] Menno P. Witter,et al. Trans-Synaptic Spread of Tau Pathology In Vivo , 2012, PloS one.
[63] P. Davies,et al. Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology , 2009, The Journal of Neuroscience.
[64] Naruhiko Sahara,et al. Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.
[65] H. Braak,et al. Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.
[66] J. Gallo,et al. Tau alternative splicing in familial and sporadic tauopathies. , 2012, Biochemical Society transactions.
[67] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[68] E. Mandelkow,et al. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. , 1999, Biochemistry.
[69] D. Wilcock,et al. Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease , 2010, Neuroscience.
[70] Christian Griesinger,et al. Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.
[71] Christian Wider,et al. Etiology and Pathophysiology of Frontotemporal Dementia, Parkinson Disease and Alzheimer Disease: Lessons from Genetic Studies , 2008, Neurodegenerative Diseases.
[72] M. Mercken,et al. Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[73] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[74] J. Götz,et al. Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.
[75] Dennis W. Dickson,et al. Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.
[76] M. Diamond,et al. Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.
[77] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[78] C. Hoogenraad,et al. Maintenance of Dendritic Spine Morphology by Partitioning-Defective 1b through Regulation of Microtubule Growth , 2011, The Journal of Neuroscience.
[79] H. Steinhoff,et al. Microtubule Binding and Trapping at the Tip of Neurites Regulate Tau Motion in Living Neurons , 2009, Traffic.
[80] C. Richter-Landsberg. The Cytoskeleton in Oligodendrocytes , 2008, Journal of Molecular Neuroscience.
[81] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[82] Brian J. Bacskai,et al. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo , 2013, Proceedings of the National Academy of Sciences.
[83] K. Blennow,et al. The Neuropathology and Neurobiology of Traumatic Brain Injury , 2012, Neuron.
[84] Bin Zhang,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[85] Matthew N. Rasband,et al. The axon initial segment and the maintenance of neuronal polarity , 2010, Nature Reviews Neuroscience.
[86] P. Baas,et al. Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases. , 2011, Human molecular genetics.
[87] Carsten Janke,et al. Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton , 2010, Trends in Neurosciences.
[88] F. van Leuven,et al. Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice , 2011, The Journal of Neuroscience.
[89] A. Takashima,et al. Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild‐type human tau , 2007, The EMBO journal.
[90] S. Kaech,et al. Culturing hippocampal neurons , 2006, Nature Protocols.
[91] E. Mandelkow,et al. Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.
[92] E. Mandelkow,et al. MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons , 2004, The Journal of cell biology.
[93] E. Mandelkow,et al. The tau of MARK: a polarized view of the cytoskeleton. , 2009, Trends in biochemical sciences.
[94] N. Hirokawa,et al. Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice , 2000, Neuroscience Letters.
[95] D. Dickson,et al. Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. , 2009, The American journal of pathology.
[96] A. Andreadis. Tau splicing and the intricacies of dementia , 2012, Journal of Cellular Physiology.
[97] L. Mucke,et al. Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[98] Jianhua Shi,et al. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. , 2010, Journal of Alzheimer's disease : JAD.
[99] B. Riederer,et al. Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein , 2007, Brain Research Bulletin.
[100] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[101] Brian M. Barnes,et al. The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation , 2011, PloS one.
[102] F. van Leuven,et al. Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.
[103] R. Neve,et al. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.
[104] B. Hyman,et al. Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.
[105] Defects in Axonal Elongation and Neuronal Migration in Mice with Disrupted tau and map1b Genes , 2000, The Journal of cell biology.
[106] E. Mandelkow,et al. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.
[107] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[108] M. Kirschner,et al. A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[109] D. Holtzman,et al. In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice , 2011, The Journal of Neuroscience.
[110] Bin Zhang,et al. Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies , 2005, The Journal of Neuroscience.
[111] F. LaFerla,et al. Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles* , 2006, Journal of Biological Chemistry.
[112] E. Mandelkow,et al. Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration , 2011, The EMBO journal.
[113] Frank Bradke,et al. Control of neuronal polarity and plasticity--a renaissance for microtubules? , 2009, Trends in cell biology.
[114] E. Mandelkow,et al. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.
[115] E. Mandelkow,et al. Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based Biosensor , 2011, The Journal of Biological Chemistry.
[116] E. Mandelkow,et al. Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons , 2007, The Journal of Neuroscience.
[117] O. Lindvall,et al. Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.
[118] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[119] J. Trojanowski,et al. Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy , 2011, The Journal of Neuroscience.
[120] Frank M LaFerla,et al. Animal models of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[121] U. Sengupta,et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau , 2012, Scientific Reports.
[122] W. Noble,et al. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.
[123] B Miller,et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.
[124] J. Mandell,et al. The microtubule cytoskeleton and the development of neuronal polarity , 1995, Neurobiology of Aging.
[125] E. Mandelkow,et al. Degradation of tau protein by autophagy and proteasomal pathways. , 2012, Biochemical Society transactions.
[126] C. Haass,et al. Loss of fused in sarcoma (FUS) promotes pathological Tau splicing , 2012, EMBO reports.
[127] A. Lees,et al. The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons , 2002, The Journal of Neuroscience.
[128] M. Vitek,et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.
[129] Tsuyoshi Morita,et al. Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway* , 2009, The Journal of Biological Chemistry.